C5orf34_4833420G17Rik Activators
C5orf34 activators encompass a range of chemical compounds that indirectly stimulate the functional activity of C5orf34 through various intracellular signaling pathways. Compounds such as Forskolin, IBMX, and Rolipram work by increasing cAMP levels, which activate PKA and potentially enhance C5orf34 activity through phosphorylation of downstream targets within cAMP-dependent signaling networks. Additionally, the use of Dibutyryl-cAMP, a synthetic cAMP analog, provides a direct mechanism to activate these pathways and potentially amplify the functional role of C5orf34. Sildenafil and L-Arginine act through the nitric oxide signaling pathway by increasing cGMP levels, suggesting a possible enhancement of C5orf34's activity through cGMP-dependent protein kinases or cross-talk with cAMP signaling. Furthermore, A23187 and PMA directly modulate calcium and PKC signaling, respectively, which are crucial regulators of a multitude of cellular functions that could intersect with C5orf34's role in the cell.
The activity of C5orf34 is further influenced by the modulation of specific kinase pathways. Y-27632, a ROCK inhibitor, PD 98059, an MEK inhibitor, and LY294002, a PI3K inhibitor, all perturb cytoskeletal dynamics, MAPK/ERK, and PI3K/Akt signaling pathways respectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. The rise in calcium can activate calcium-dependent signaling pathways, such as calmodulin-dependent kinases, which may subsequently phosphorylate proteins that interact with or regulate C5orf34, thus enhancing the activity of C5orf34 through post-translational modifications. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC leads to phosphorylation of target proteins that might interact with or modify C5orf34, resulting in the enhancement of C5orf34's functional activity through altered protein-protein interactions or changes in protein stability. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that resists degradation by phosphodiesterases. By mimicking cAMP, it activates PKA, potentially leading to phosphorylation of proteins that associate with or modulate C5orf34 function, thereby enhancing the activity of C5orf34. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent proteins that could modify C5orf34 function. This activation can enhance the activity of C5orf34 through calcium-dependent pathways, potentially affecting its protein interactions or stability. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, potentially altering signaling pathways that converge on C5orf34. By inhibiting competitive pathways, EGCG may enhance the activity of C5orf34 by channeling cellular signaling through C5orf34-related pathways or by reducing phosphorylation of proteins that negatively regulate C5orf34. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which can lead to downstream alterations in the Akt signaling pathway. By modulating this pathway, LY294002 might enhance C5orf34 activity indirectly by affecting the phosphorylation state of interacting proteins or by shifting cellular signaling towards pathways that utilize C5orf34. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that can modify the MAPK/ERK pathway, potentially affecting proteins that regulate or interact with C5orf34. By inhibiting MEK, U0126 may lead to a compensatory enhancement of alternative pathways that involve C5orf34, thus indirectly increasing its functional activity. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can modulate ion channels and influence intracellular signaling cascades. Through its effects on cellular ionic balance and signaling, spermine might enhance the activity of C5orf34 by modulating the electrochemical environment or signaling context in which C5orf34 operates. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of various proteins. This inhibitory effect on phosphatases may result in the enhancement of phosphorylation-dependent processes involving C5orf34, thereby increasing its activity. | ||||||